Efficacy of Oral Probiotic Supplementation in Preventing Vulvovaginal Infections During Pregnancy: A Randomized and Placebo-Controlled Clinical Trial
2024

Probiotics and Vulvovaginal Infections in Pregnant Women

Sample size: 100 publication 10 minutes Evidence: moderate

Author Information

Author(s): Yefet Enav, Suleiman Abeer, Colodner Raul, Battino Shlomo, Wattad Malak, Kuzmin Olga, Nachum Zohar

Primary Institution: Tzafon Medical Center, Poriya, Israel

Hypothesis

Does oral probiotic supplementation prevent vulvovaginal infections in pregnant women?

Conclusion

The oral probiotic product did not reduce the rate of vulvovaginal infections in pregnant women with normal vaginal flora.

Supporting Evidence

  • The rate of vulvovaginal infections was similar in both the probiotic and placebo groups.
  • No woman had vaginal colonization with lactobacilli from the probiotic capsule.
  • Women in the probiotic group reported less pruritus at the last visit.

Takeaway

The study tested if taking probiotics could help pregnant women avoid infections down there, but it didn't work.

Methodology

A multicenter, double-blind, randomized, placebo-controlled trial was conducted with pregnant women receiving either probiotics or placebo.

Potential Biases

Potential bias due to the exclusion of women with certain conditions and reliance on self-reported symptoms.

Limitations

The study population included women with different types of infections, and it was not powered to evaluate pregnancy and neonatal outcomes.

Participant Demographics

Pregnant women aged 18 and older, with normal vaginal flora, recruited from outpatient clinics.

Statistical Information

P-Value

0.80

Statistical Significance

p = 0.80

Digital Object Identifier (DOI)

10.3390/nu16244406

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication